Healthcare Leadership, Policy & Digital Health News IndiaHealthcare Leadership, Policy & Digital Health News IndiaHealthcare Leadership, Policy & Digital Health News India
  • Home
  • News
  • Articles
  • Exclusive
  • HB Originals
  • Gallery
  • Advertisement
Healthcare Leadership, Policy & Digital Health News IndiaHealthcare Leadership, Policy & Digital Health News India
  • Medical Science
Search
  • Home
  • Categories
    • Medical Science
    • Health Awareness
  • Bookmarks
  • More Foxiz
    • Sitemap
Follow US
  • Advertise
© 2025 Health Hub Media Pvt Ltd. All Rights Reserved.
Healthcare Leadership, Policy & Digital Health News India > Blog > Global News > TrumpRx Launches! Government Portal Offers Cash-Pay Discounts on Dozens of Brand-Name Drugs for Direct-to-Patient Purchases

TrumpRx Launches! Government Portal Offers Cash-Pay Discounts on Dozens of Brand-Name Drugs for Direct-to-Patient Purchases

Published: February 7, 2026
SHARE

The Trump administration has launched TrumpRx.gov, a government-run online portal that directs cash-paying patients to discounted prices on select prescription drugs through manufacturer channels. Powered by GoodRx technology, the site displays cash prices (often aligned with “most-favored-nation” rates) for over 40 branded medications from initial partners like Pfizer, Eli Lilly, Novo Nordisk, AstraZeneca, and others, without selling drugs directly. It aims to provide immediate savings for uninsured or cash-paying individuals by bypassing insurance, though experts note limited impact for the majority with coverage.

Glimpse:

TrumpRx.gov debuted February 5, 2026, following a brief delay, offering searchable cash prices and links to manufacturer platforms or printable coupons for redemption at pharmacies. It features 40+ popular and high-cost branded drugs, with discounts up to 85% and average savings around 50% off list prices compared to private-sector rates. The portal targets uninsured patients or those opting out of insurance, integrates with the administration’s Most Favored Nation (MFN) drug pricing deals, and emphasizes transparency and patient choice. While not insurance-compatible, it provides a direct-to-patient option amid ongoing efforts to lower U.S. drug costs.

President Donald Trump unveiled TrumpRx.gov on February 5, 2026, in a White House event, launching a federal platform designed to help Americans access dramatically lower prices on prescription drugs through cash-pay channels. The government-hosted website does not sell medications directly but serves as a searchable portal displaying cash prices for select branded drugs and redirecting users to third-party platforms often run by manufacturers—where patients can complete purchases or obtain coupons for use at local pharmacies.

The initiative ties into the administration’s Most Favored Nation (MFN) drug pricing policy, under which more than a dozen major pharmaceutical companies have agreed to offer U.S. prices closer to those in other developed nations. Initial partners include AstraZeneca, Eli Lilly, EMD Serono (Merck KGaA), Novo Nordisk, and Pfizer, with over 40 high-cost and commonly used medications listed at launch. Examples include GLP-1 treatments like Wegovy, where patients must opt out of insurance counting toward deductibles. Discounts can reach up to 85%, with average savings of around 50% compared to private-sector list prices, according to Pfizer and White House statements.

TrumpRx uses pricing technology from GoodRx to display transparent cash rates. Users search by drug name, view available offers, and follow manufacturer-specific instructions such as downloading coupons or accessing direct fulfillment channels. The portal explicitly notes that discounted pricing is available only for cash-paying patients, with no insurance integration at this time. It requires a valid prescription, and patients can redeem offers at participating pharmacies or through manufacturer programs.

The launch follows months of buildup, including initial teases in September 2025 and a brief delay in January 2026 amid concerns over antitrust issues, transparency, and potential anti-kickback law violations raised by Democratic senators. HHS guidance issued in late January clarified pathways for manufacturers to offer direct-to-patient discounts safely. While aimed at providing “immediate relief” for cash-paying individuals, experts point out that about 85% of Americans have prescription drug coverage through insurance, potentially limiting broad impact. Critics have called it a “glorified coupon book,” while supporters highlight its role in promoting competition and patient choice.

The administration envisions expanding the list of drugs and partners, positioning TrumpRx as a key step in transforming prescription drug access and affordability for Americans.

“Starting tonight, dozens of the most commonly used prescription drugs will be available at dramatic discounts for all consumers through a new website called TrumpRx.gov. People are going to save a lot of money and be healthy.”

By

HB Team

Related News

Amneal’s Billion Dollar Bet: Building a Global Biosimilars Powerhouse

April 24, 2026

OpenAI Unveils ChatGPT for Clinicians to Cut Paperwork and Transform Patient Care

April 24, 2026

eClinicalWorks Unveils Smart CCM Service to Cut Staff Burden and Boost Chronic Care

April 24, 2026

India & Brazil Strengthen Pharma Ties with New Regulatory Cooperation Pact

April 23, 2026

Oura Acquires Galen AI to Build Unified Personal Health Platform

April 23, 2026

AcuityMD Raises $80M to Power Agentic AI Revolution in MedTech

April 23, 2026

Proximie and NVIDIA Join Forces to Build AI-Powered Intelligent Operating Rooms

April 22, 2026

Atropos Health Launches “Alexandria” to Build World’s Largest AI-Powered Medical Evidence Library

April 22, 2026

UnitedHealth Bets $1.5B on AI to Power Turnaround and Cut Healthcare Costs

April 22, 2026

Medtronic Strengthens Heart Care Portfolio with $585M CathWorks Acquisition

April 22, 2026

AI Upgrade Turns NHS App into Real Time Appointment Booking Hub for Millions

April 21, 2026

AI Adoption Surges Across EU Healthcare, But Safety Gaps Raise Concerns

April 21, 2026

GE HealthCare Expands AI Alliance to Boost Early Breast Cancer Detection Worldwide

April 18, 2026

NTU’s AI Biochip Detects Diseases in 20 Minutes, Paving Way for Rapid Diagnostics

April 18, 2026

Oracle Health Pushes Paperless Future with QR Check-In and Interoperable Data Network

April 21, 2026

Singapore Trials AI That Lets Paralysed Patients Speak Through Blinks

April 20, 2026

QNX and NVIDIA Deepen Partnership to Power Safer AI in Medical Devices and Robotics

April 20, 2026

Strados Labs Expands Respiratory Trial Capabilities with Strategic NuvoAir Acquisition

April 20, 2026

APA Launches Trusted Digital Library to Cut Through Mental Health App Overload

April 20, 2026

Verily Workbench Goes Live on AWS to Accelerate AI Driven Biomedical Research

April 17, 2026
WHO Cautions on Possible Global Spread of Toxic Cough Syrups via Unregulated Channels
Pinky Promise Launches India’s First AI-Led Digital Clinic for Women, Raises $1M Pre-Seed Funding
Sakra World Hospital Launches Dedicated Institute of Cancer Care and Blood Disorders in Bengaluru
Halfway Isn’t Safe! Why Quitting Antibiotics Early Can Backfire
Blackstone and TPG Complete $13.75 Billion Acquisition of Hologic, Appoint Joe Almeida as New CEO
Your browser does not support the audio element.
Your browser does not support the audio element.

Contact us

Privacy Policy

Terms & Conditions

HealthBuzz is a leading platform for healthcare news in India, covering hospital leadership updates, health policy developments, digital health innovations, and emerging healthcare startups. Stay informed with the latest insights shaping India’s healthcare ecosystem.

Facebook Twitter Youtube Whatsapp

Quick Links

  • Home
  • Articles
  • HB Originals
  • News
  • Videos
  • Gallery

Company

  • About us
  • Contact Us
  • Privacy Policy
  • Terms & Conditions
  • Content Complaince

Install our Mobile App for Best Experience

Healthcare Leadership, Policy & Digital Health News IndiaHealthcare Leadership, Policy & Digital Health News India
Follow US
Health Hub Media Pvt. Ltd. © 2026 All Rights Reserved
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?